Novian Health Inc. developed Novilase® Interstitial Laser System for the treatment of malignant breast tumors for adult women who undergo breast conserving procedure. The laser therapy helps patients by keeping away from trauma and works as an alternative for breast cancer surgery.
Novilase is a minimally invasive procedure which destroys tumors with the use of laser ablation resulting as an alternative procedure to surgery. This is applicable for the focal damaging of malignant tumors of the breast up to 15 mm including incision, excision, and ablation of soft tissues; and coagulative necrosis and interstitial laser coagulation of soft tissues.
In U.S, every year more than 275,000 women and approximately 2 million in the world are diagnosed with breast cancer.
Lumpectomy, is a surgical procedure for breast cancer. Most of the breast cancer patients and their doctors prefer to remove tumors surgically in breast-conserving procedure called lumpectomy. Though patients treated with this procedure 25 percent of women may need additional surgery as the entire tumors are not removed during the initial surgical procedure.
In Novilase procedure, laser probe is inserted directly into the tumor by using ultrasound guidance. The tumor is then heated by the laser and destroyed.
U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for its Novilase® Interstitial Laser System for the treatment of breast cancer.
